Q4 2020: Strong finish to a successful year
Significant events during the fourth quarter · Net sales increased by 11% (20% adjusted for currency changes) to SEK 185 m (166). · EBITDA margin was 25% (32%). · Acquisition of shares and strategic partnership in Vital Nutrients Holdings. The acquisition amounted to USD 6 m and represents slightly less than 10% ownership. · Publication of major study confirms using Probi Defendum® has a positive effect on common colds. Significant events during full-year 2020 · Net sales increased by 15% (17% adjusted for currency changes) to SEK 717 m (626). · The EBITDA margin